Peter Riedell to Antibodies, Monoclonal, Murine-Derived
This is a "connection" page, showing publications Peter Riedell has written about Antibodies, Monoclonal, Murine-Derived.
Connection Strength
0.552
-
A drug safety evaluation of rituximab and risk of hepatitis B. Expert Opin Drug Saf. 2014 Jul; 13(7):977-87.
Score: 0.486
-
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans. J Natl Cancer Inst. 2016 11; 108(11).
Score: 0.035
-
Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone. Br J Haematol. 2014 Dec; 167(5):699-702.
Score: 0.031